---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-064735"
form_type: "8-K"
ticker: "SILO"
cik: "0001514183"
company_name: "Silo Pharma, Inc."
filed_at: "2022-10-18T23:59:59+00:00"
generated_at: "2026-06-23T02:57:14.387557+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Silo Pharma hires Eric Weisblum as CEO with $350K salary, extends Columbia research pact

## Summary
- Eric Weisblum appointed CEO; base salary $350K/yr, signing bonus $100K, annual bonus up to $350K.
- Severance includes 24 months base salary, COBRA coverage, and prorated bonus on termination without cause or change in control.
- Columbia University agreement extended; option to license SPC-14 (Alzheimer's) and SPC-15 (stress-induced anxiety).
- CFO Daniel Ryweck salary increased to $60K/yr per amendment dated October 12, 2022.

## SEC filing metadata
- accession: 0001213900-22-064735
- form_type: 8-K
- ticker: SILO
- cik: 0001514183
- company_name: Silo Pharma, Inc.
- filed_at: 2022-10-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 5.02, 7.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1514183/000121390022064735/0001213900-22-064735-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1514183/000121390022064735/ea167262-8k_silopharma.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-064735
- JSON: https://secwatch.observer/filing/0001213900-22-064735.json
- Plain text: https://secwatch.observer/filing/0001213900-22-064735.txt

## Key facts
- Executive change
  Eric Weisblum was appointed as Chief Executive Officer at Silo Pharma, Inc..
  - Action: appointed
  - Role: Chief Executive Officer
  source text: On October 12, 2022, the Company entered into an employment agreement with Eric Weisblum (the “Weisblum Employment Agreement”)
  evidence_url: https://www.sec.gov/Archives/edgar/data/1514183/000121390022064735/0001213900-22-064735-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.